tiprankstipranks
Trending News
More News >

Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval

Story Highlights
Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval

Confident Investing Starts Here:

Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has shared an announcement.

Shandong Xinhua Pharmaceutical Company Limited announced that its Aspirin Enteric-coated Tablets have passed the Generics Drugs Consistency Evaluation, receiving approval from the National Medical Products Administration. This approval signifies a positive step for the company, enhancing its product offerings and potentially strengthening its position in the pharmaceutical market.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, primarily involved in the production and distribution of chemical medicines. The company focuses on prescription drugs and has a market presence in the pharmaceutical industry.

YTD Price Performance: -3.10%

Average Trading Volume: 2,170,030

Technical Sentiment Signal: Sell

Current Market Cap: HK$8.56B

Find detailed analytics on 0719 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App